DNMT3A and acute myeloid leukemia: Dec and Aza inhibited proliferation and promoted apoptosis of AML cell lines MV4-11, SKM-1, and DNMT3A mutant SKM-1 cells dose-dependently (Figures 5A, B, S3A, B).